Total Payments
$8,475
2024 Payments
$1,479
Companies
45
Transactions
516
Medicare Patients
2,376
Medicare Billing
$233,396
Payment Breakdown by Category
Food & Beverage$8,444 (99.6%)
Education$31.71 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,444 | 511 | 99.6% |
| Education | $31.71 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,848 | 65 | $0 (2024) |
| Novo Nordisk Inc | $1,385 | 89 | $0 (2024) |
| PFIZER INC. | $842.65 | 58 | $0 (2024) |
| Lilly USA, LLC | $670.75 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $541.96 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $483.19 | 38 | $0 (2023) |
| ABBVIE INC. | $288.64 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $206.40 | 30 | $0 (2023) |
| Amarin Pharma Inc. | $189.03 | 13 | $0 (2023) |
| Amgen Inc. | $174.42 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,479 | 59 | AstraZeneca Pharmaceuticals LP ($615.21) |
| 2023 | $861.95 | 47 | Lilly USA, LLC ($234.30) |
| 2021 | $71.30 | 5 | Novo Nordisk Inc ($26.89) |
| 2020 | $670.40 | 41 | AstraZeneca Pharmaceuticals LP ($218.96) |
| 2019 | $2,493 | 154 | Novo Nordisk Inc ($622.55) |
| 2018 | $1,072 | 93 | Novo Nordisk Inc ($213.65) |
| 2017 | $1,828 | 117 | AstraZeneca Pharmaceuticals LP ($292.16) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $118.63 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: PAIN | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 599 | 757 | $267,070 | $65,596 |
| 2022 | 11 | 517 | 690 | $236,860 | $54,070 |
| 2021 | 9 | 563 | 675 | $194,420 | $59,079 |
| 2020 | 16 | 697 | 831 | $200,325 | $54,651 |
Total Patients
2,376
Total Services
2,953
Medicare Billing
$233,396
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 244 | $105,835 | $21,444 | 20.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $55,940 | $17,510 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 96 | $58,340 | $13,174 | 22.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 52 | $5,720 | $3,717 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 54 | $16,665 | $2,753 | 16.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $7,410 | $2,303 | 31.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $6,220 | $1,938 | 31.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 55 | $5,640 | $1,808 | 32.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 81 | 83 | $4,150 | $777.28 | 18.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 23 | $1,150 | $172.92 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 250 | $108,540 | $21,269 | 19.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $40,415 | $13,158 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 88 | $53,560 | $12,391 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 68 | $21,010 | $3,809 | 18.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,760 | $1,080 | 61.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 21 | $4,075 | $603.31 | 14.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $1,800 | $588.78 | 32.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 63 | 66 | $3,300 | $559.49 | 17.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 31 | $1,550 | $340.44 | 22.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $845.00 | $269.62 | 31.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 28 | $5.27 | $1.46 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 226 | $83,620 | $22,571 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 103 | 103 | $40,685 | $15,130 | 37.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 64 | $31,360 | $9,522 | 30.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 56 | 56 | $6,160 | $3,655 | 59.3% |
About Dr. Jennifer Reimer, D.O
Dr. Jennifer Reimer, D.O is a Internal Medicine healthcare provider based in Point Pleasant Boro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1558651208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Reimer, D.O has received a total of $8,475 in payments from pharmaceutical and medical device companies, with $1,479 received in 2024. These payments were reported across 516 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,444).
As a Medicare-enrolled provider, Reimer has provided services to 2,376 Medicare beneficiaries, totaling 2,953 services with total Medicare billing of $233,396. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Point Pleasant Boro, NJ
- Active Since 04/14/2011
- Last Updated 11/30/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558651208
Products in Payments
- FARXIGA (Drug) $1,322
- Ozempic (Drug) $601.97
- Saxenda (Drug) $396.06
- JANUVIA (Drug) $355.88
- BREZTRI (Drug) $275.01
- MOUNJARO (Drug) $262.61
- VRAYLAR (Drug) $253.46
- TRELEGY ELLIPTA (Drug) $238.14
- ELIQUIS (Drug) $222.07
- ANORO (Drug) $208.09
- CHANTIX (Drug) $198.82
- Vascepa (Drug) $189.03
- Cologuard Collection Kit (Device) $168.89
- Trintellix (Drug) $158.28
- EMGALITY (Drug) $146.42
- AIRSUPRA (Drug) $140.99
- ZAVZPRET (Drug) $118.63
- Otezla (Drug) $115.94
- TRULICITY (Drug) $115.62
- Amitiza (Drug) $107.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.